Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Patent
1998-04-17
2000-02-15
Kulkosky, Peter F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
514825, 426655, A61K 3578
Patent
active
060249609
ABSTRACT:
A formulation having a rose hip concentrate is used to treat and/or alleviate the symptoms associated with inflammation including arthritis or to prevent development of arthritis. The rose hip concentrate has a high vitamin content relative to conventionally dried material, and is shown, in vitro, to inhibit the chemotaxis and oxidative burst response of human peripheral blood inflammatory cells, as well as the chemotaxis of monocytes. The formulation, in vivo, was found to inhibit chemotaxis of human peripheral blood inflammatory cells and to reduce the level of C-reactive protein, to alleviate pain and reduce inflammation in patients with arthritis.
REFERENCES:
patent: 4774229 (1988-09-01), Jordan
patent: 5744187 (1998-04-01), Gaynor
CA104: 174649 F. Morishige Nissan Chem. Ind. Ltd. Japan Dec. 11, 1985.
CA 101:136 B. Spilker et al 1984 (35)(4) 593-605.
Fabad.J.Pharm. Sci. 15, 121-131, 1990 S.Kurucu et al.
Kharazmi Arsalan
Rein Eydbj.o slashed.rg
Winther Kaj
Kulkosky Peter F.
Otto Torbjorn Hansen and Marianne Hansen
LandOfFree
Rose-hip formulations as anti-inflammatory natural medicine for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rose-hip formulations as anti-inflammatory natural medicine for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rose-hip formulations as anti-inflammatory natural medicine for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1903574